Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to the diverse population of antibodies, primarily of the IgE and IgG isotypes, that specifically bind to antigenic determinants (epitopes) derived from the house dust mite Dermatophagoides pteronyssinus and various respiratory bacteria. In allergic individuals, the IgE component of these polyclonal immunoglobulins mediates the hypersensitivity response by triggering mast cell and basophil degranulation upon allergen exposure (Source: Journal of Allergy and Clinical Immunology, 2014). Therapeutic strategies, such as allergen-specific immunotherapy (AIT), aim to modulate this target by shifting the immune response from a Th2-dominated IgE production toward a Th1/Treg-dominated production of protective 'blocking' IgG antibodies (Source: Nature Reviews Immunology, 2006). These induced IgG antibodies compete with IgE for the same epitopes on the mite and bacterial antigens, thereby preventing the allergic cascade and reducing clinical symptoms. This target is particularly relevant in the management of allergic rhinitis and asthma, especially when these conditions are exacerbated by recurrent bacterial respiratory infections (Source: AdisInsight, 2023).
Induction of allergen-specific blocking IgG antibodies and modulation of T-cell cytokine profiles to favor immune tolerance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyclonal immunoglobulins recognizing Dermatophagoides pteronyssinus and bacterial extract epitopes.